17 results
Keyword Quviviq Remove keyword
-
List item
Human medicine European public assessment report (EPAR): Quviviq (updated)
daridorexant hydrochloride, Sleep Initiation and Maintenance Disorders
Date of authorisation: 29/04/2022,
, Revision: 4, Authorised, Last updated: 17/03/2023
Quviviq Sleep Disorders, Intrinsic Dyssomnias Sleep … orised daridorexant Overview Quviviq is a medicine for treating … function during the day. Quviviq contains the The substance … -
List item
News: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 21-24 February 2022
CHMP, Last updated: 25/02/2022Quviviq … -
List item
List of medicines under additional monitoring
Last updated: 22/02/2023 -
List item
Committee for Medicinal Products for Human Use (CHMP): 20-23 February 2023
European Medicines Agency, Amsterdam, the Netherlands, from 20/02/2023 to 23/02/2023, Last updated: 20/02/2023 -
List item
Newsletters (updated)
Last updated: 09/03/2023 -
List item
Committee for Medicinal Products for Human Use (CHMP): 21-24 March 2022
European Medicines Agency, Amsterdam, the Netherlands, from 21/03/2022 to 24/03/2022, Last updated: 12/08/2022 -
List item
Download medicine data
Last updated: 02/12/2021 -
List item
CHMP: Agendas, minutes and highlights
Last updated: 08/02/2023 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 6-9 February 2023
European Medicines Agency, Amsterdam, the Netherlands, from 06/02/2023 to 09/02/2023, Last updated: 18/08/2021 -
List item
News: Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 6 - 9 February 2023
PRAC, Last updated: 10/02/2023 -
List item
News: Human medicines: highlights of 2022
Last updated: 16/02/2023fumarate Teva Melatonin Neurim Quviviq Rayvow Sugammadex Amomed … -
List item
PRAC: Agendas, minutes and highlights (updated)
Last updated: 17/03/2023 -
List item
EMA event supporting materials
Last updated: 14/06/2022 -
List item
Committee for Medicinal Products for Human Use (CHMP): 21-24 February 2022
European Medicines Agency, Amsterdam, the Netherlands, from 21/02/2022 to 24/02/2022, Last updated: 06/04/2021 -
List item
Committee for Medicinal Products for Human Use (CHMP): 18-21 July 2022
European Medicines Agency, Amsterdam, the Netherlands, from 18/07/2022 to 21/07/2022, Last updated: 06/04/2021 -
List item
Committee for Medicinal Products for Human Use (CHMP): 12-15 September 2022
European Medicines Agency, Amsterdam, the Netherlands, from 12/09/2022 to 15/09/2022, Last updated: 06/04/2021 -
List item
Public data from Article 57 database
Last updated: 17/10/2022